Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-02-20 @ 9:11 AM
Study NCT ID:
NCT05642468
Status:
COMPLETED
Last Update Posted:
2025-07-30
First Post:
2022-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
Sponsor:
Albireo, an Ipsen Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A3907-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None